Elon Musk’s Neuralink Says FDA Gave Approval for Human Trials
Summary from the AllSides News Team
Neuralink tweeted Thursday that it had received FDA approval for a “first-in-human clinical study” of its brain implant.
For Context: Co-founded by Elon Musk in 2016, Neuralink is developing implants it hopes will help cure paralysis and other neurological ailments. In November 2022, Musk predicted that the company was six months away from the first human trial, echoing previous predictions of FDA approval since 2019. Reuters (Center bias) reported in March 2023 that the FDA rejected a prior human trials application in early 2022, citing “dozens of issues the company must address.” Separately, the company came under federal investigation in early 2022 after an animal rights group accused Neuralink researchers of “mutilating” monkeys’ brains, causing “extreme suffering.”
The Details: In its announcement, the brain chip company added: “This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.” The FDA also acknowledged the decision on Friday.
How the Media Covered It: Coverage was common across the spectrum, particularly in tech outlets. Most coverage prominently featured Musk’s involvement in Neuralink. Some coverage from the left focused more on animal rights concerns, while some coverage from the right highlighted the technical potential of brain implants.
Update 5/26: Neuralink's tweet was posted Thursday evening, not Friday morning, as previous version stated.
Featured Coverage of this Story
From the Center
Elon Musk’s brain implant company Neuralink announces FDA approval of in-human clinical study
Neuralink, the neurotech startup co-founded by Elon Musk, announced Thursday it has received approval from the Food and Drug Administration to conduct its first in-human clinical study.
Neuralink is building a brain implant called the Link, which aims to help patients with severe paralysis control external technologies using only neural signals. This means patients with severe degenerative diseases like ALS could eventually regain their ability to communicate with loved ones by moving cursors and typing with their minds.
“This is the result of incredible work by the Neuralink team in close collaboration with the...
From the Right
Elon Musk’s brain implant technology gains FDA approval
Elon Musk’s company Neuralink announced Thursday that it received approval from the Food and Drug Administration (FDA) to conduct its first-in-human clinical study.
"We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study," the company said in a tweet.
Musk helped co-found Neuralink, a neurotechnology company working to develop brain implants that could someday help people who are paralyzed walk again, as well as help with other neurological issues.
Since 2019, Musk has been predicting that Neuralink would get approval from the FDA for human...
From the Left
Elon Musk's brain implant company Neuralink says the FDA has approved human trials
Neuralink has announced that the U.S. Food and Drug Administration (FDA) has approved the launch of its first clinical study in humans.
"We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!" Neuralink's official Twitter account wrote on Thursday.(opens in a new tab) "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people."
The neurotechnology company isn't recruiting test subjects...
AllSides Picks
July 3rd, 2024
July 3rd, 2024
More News about Science from the Left, Center and Right
From the Left
From the Center
From the Right
